Quantum-Si offers Next-Generation Protein Sequencing (NGPS) technology, reducing the cost and complexity of traditional protein analysis methods like mass spectrometry. The company targets a large $75 ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ™, and ...
Nucleic acid-based therapeutics, including antisense oligonucleotides (ASO), small interfering RNA (siRNA), messenger RNA (mRNA), immunomodulatory DNA/RNA, and gene-editing guide RNA (gRNA), hold ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback